PATENT CLAIM ANALYSIS

Application Number: 16090317
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "161000"]

Abstract:
Methods of treating and preventing conditions of a nasal or paranasal mucous membrane are described. The methods include administering a pharmaceutical composition including a nicotinic acetylcholine receptor (nAChR) agonist, such as (S)-(1-methyl-2-pyrrolidinyl)-pyridine, or a pharmaceutically acceptable salt, analog, precursor or derivative thereof. The methods can be used to treat a wide variety of conditions of the nasal or paranasal mucous membrane, such as nasal congestion and nose bleeds.

Claim (Index 15):
A method of treating a condition of a nasal or paranasal mucous membrane in a human subject in need thereof, the method comprising nasally administering to the nasal or paranasal mucous membrane of the subject a therapeutically effective amount of an aqueous pharmaceutical composition comprising about 0.1 mg/ml to 2.0 mg/ml of (S)-(1-methyl-2-pyrrolidinyl)-pyridine or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable diluent, excipient, or carrier, wherein the condition is selected from the group consisting of nasal congestion and nasal hemorrhages (\u201cnose bleeds\u201d).

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.57407
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14470197', '12675257', '15004807', '10912578', '13838959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.769498024903828
- 35 USC 102 Novelty (BERT): 0.5085302939182
- Combined Prediction Score: 0.7434012518052653
- Mean Citation Score: 236.049792
- Max Citation Score: 266.14062
- Similarity Product: 172.71578912055014

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test